TrialPath
Recruiting

Longterm Influence of Pediatric Long COVID Syndrome

NCT05566392 · National Taiwan University Hospital
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Longterm Influence of Pediatric Long COVID Syndrome on the Neuropsychiatric Function, Social Function, Neuroimage, and Gut Microbiota
About this study
We enroll pediatric patients who were diagnosed COVID-19 for main observation target. We will perform brain MRI and neuropsychiatric evaluation 4-6 months after COVID-19 diagnosed. We also enroll healthy age- and gender-matched participant for cross-over comparison. We will perform same evaluation process one year later for longitudinal evaluation
Eligibility criteria
Inclusion Criteria: * Age 6-18 years old * Has been diagnosed COVID-19 before Exclusion Criteria: * History of neuropsychiatric disorders * Have some device not allowed for MRI
Study design
Enrollment target: 500 participants
Age groups: child, adult
Timeline
Starts: 2022-10-20
Estimated completion: 2030-12
Last updated: 2024-08-06
Interventions
Diagnostic Test: Brain MRI
Primary outcomes
  • Difference between COVID and healthy group (1 years after enrollment for primary evaluation)
Sponsor
National Taiwan University Hospital · other
Contacts & investigators
ContactWang-Tso Lee, PHD · contact · leeped@hotmail.com · (886)2-23123456
InvestigatorWang-Tso Lee, PHD · principal_investigator, National Taiwan University Children Hospital Pediatric neurology department
All locations (1)
National Taiwan University Children Hospital Pediatric Neurology DepartmentRecruiting
Taipei, Taiwan
Longterm Influence of Pediatric Long COVID Syndrome · TrialPath